A Randomized Controlled Pilot Study Comparing Air Fluidized Therapy (AFT) to a Continuous Low Pressure (CLP) Low Air Loss (LAL) Support Surface in the Treatment of Stage 3 or 4 Pressure Injuries
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 5
- 试验地点
- 4
- 主要终点
- Pressure ulcer healing
研究概览
简要总结
Patients who have at least one stage 3 or 4 PI and are admitted to a participating treating facility will be candidates for study enrollment. Patients must provide written informed consent. Standard care for their admitted condition will be provided for the patients except for support surface selection, laboratory blood tests, PI measurement(s) by the 3-D camera measurement tool, and added pain and patient satisfaction assessments. Clinical assessments will be recorded weekly as described below. Patients will be followed until discharge from the LTACH or until 1) they require a different mattress for their admitted condition; or 2) reach a maximum of 12 weeks in the LTACH. At study discontinuation, a clinical general assessment of the quality of improvement of the PIs will be recorded.
详细描述
Patients admitted to the LTACH with at least one stage 3 or 4 PI will be evaluated for possible inclusion/exclusion criteria. Patients will be approached by the investigator, or their designee to acquire patient informed consent. If provided, patients will be randomized to their designated support surface, the bed will be ordered and patients will begin the study with a baseline study visit (week 0) that will include:
- Date and time of study bed placement
- A brief medical history, that includes current diagnoses, assessment of co-morbidities, an assessment of neurologic status, nutritional status, level of mobility, history of current PI's, documentation of treatments that have been applied to PI(s) prior to study entry
- Braden PU risk assessment (overall and subscores)
- Assessment of pain associated with the PI using a pain numeric rating scale (NRS), where patients rate their current pain intensity from 0 ("no pain") to 10 ("worst possible pain") [21]
- Blood for CBC, Albumin, Pre-Albumin, CRP will be collected.
- PI assessments: all PI's located on the lower truncal region of the patient's body will be assessed both subjectively by the treating clinicians for clinical signs of infection, as well as by a 3D wound assessment tool.
- Overall health status assessment
Subsequent weekly study visits will continue for a maximum of 12 weeks. The interim study visit documentation will include:
- Overall health status assessment of health (whether the patient's health is improving, maintaining, or worsening)
- Skin assessment to document any new PI's that may have developed,
- Braden PU risk assessment (overall and subscores)
- 3D Wound assessments of all lower truncal PI's,
- Clinical Assessment of signs and symptoms of wound infection
- Confirmation of support surface type,
- Documentation of adverse device effects, device-related complaints (within 24 hours of effect/complaint).
Clinical Resource Utilization Data: documentation of the following data will aim to achieve estimated clinical resources associated with caring for PIs:
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient's treatment goals are curative or maintaining, and not palliative in nature.
- •Patient is compliant with standard clinical care for their admitted condition.
- •Patient's age is between 18 and 85 years
- •Patient is expected to have at least a 3-4-week length of stay (from date of assessment) in the treating LTACH
- •Patient must have at least one stage 3 or 4 PI located on the weight bearing aspect of the patient's truncal /pelvic region
- •Patients or their legal authorized representative must be willing and able to provide written informed consent.
排除标准
- •Patient has an unstable spinal cord injury
- •Patient weighs less than 70 lbs or more than 350 lbs.
- •The primary study PI site has had previous flaps or grafts with significant associated scarring which is clinically thought to impede wound contracture.
- •Patients with PIs where bone exposure is > 2 cm2 in area.
- •Patients with active osteomyelitis (via clinical assessment) or patients who have been diagnosed with osteomyelitis and have not yet completed a 6-8-week course of antibiotics
- •The primary study PI is located over the trochanteric head of the femur.
- •Patients that are currently taking or have taken in the last 6 weeks chemotherapy which is known to be cyto-toxic, or anti-angiogenic
- •Patients currently require immune modulating drugs (Humira (alalimumab), Orencia (abatacept), etc.)
研究组 & 干预措施
Air Fluidized Therapy
Patients will be placed on the Envella AFT bed
干预措施: Air Fluidized Therapy (Device)
Continuous Low Pressure-LAL
Patients will receive a Continuous low pressure mattress with low air loss
干预措施: Continuous Low Pressure-LAL (Device)
结局指标
主要结局
Pressure ulcer healing
时间窗: up to 12 weeks
Volume (mm3)
次要结局
- New Pressure Ulcers(up to 12 weeks)
- Length of stay(up to a year)